Synthetic DNA Molecules Help in Early Disease Diagnosis

Detection of single molecules of biomarkers using aptamers or synthetic DNA molecules help in early diagnosis.

A system that is specific, flexible, and can detect single protein biomarkers directly in human serum (a pool of fluid separated from blood) has been identified.

The system represents a significant innovation, as it is more sensitive to specific biomarkers and does not require clinical sample preparation.

Biomarkers Can Help Discover Lung Problems in 9/11 Firefighters
Blood biomarkers may aid in discovery of accelerated loss of lung function and airway obstruction in 9/11 firefighters who were exposed to dust at the collapse of World Trade Center.

‘Nanopores or miniscule holes that measure a change in electrical current detect the synthetic DNA that binds to specific target biomarkers.’

Dr Alex Ivanov, co-leader of this study from the Department of Chemistry at Imperial, said: "The detection of single molecules of biomarkers represents the ultimate in sensitivity for early diagnosis. We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis."

Synthetic DNA To Target Biomarkers

The method the team developed uses the ’backbone’ of DNA, the structure it is built around. They grafted ’aptamers’ - synthetic DNA molecules that bind to specific target biomarkers - to DNA backbones.

Specially Designed Sensors can Detect Biomarkers of Various Diseases
Sensors can be used for early detection of biological markers associated with infections and asymptomatic injuries such as traumatic brain injury

When added to human serum, the aptamers bind to biomarkers before being analysed by passing through a nanopore detector. Nanopores are miniscule holes (often as small as a few billionths of a meter) that measure a change in electrical current as molecules pass through them. Each biomarker has a unique current signature, so the presence and concentration of target biomarkers can be analysed in this way.

The team demonstrated that their system can work by testing three aptamers on one DNA backbone. They found that the nanopores can detect the specific biomarkers that the aptamers were designed to pick up.

Asthma Biomarkers from Lung Bacteria Identified
The lung microbiome plays a key role in asthma severity and response to treatment. Microbiome is a potential biomarker for asthma.

They say that the system can be constructed with more than five different aptamers, allowing detection of multiple biomarkers at once. In addition, the biomarkers were detected in human serum, meaning far less preparation time and cost were needed.

Based on the preliminary findings of this study, research efforts are now focused on several types of cancer and neurological disorders, which can benefit from the detection of biomarkers that are in low abundance in clinical samples.

Novel Biomarker Detects Alzheimer�s Before Onset of Symptoms
Magnetoencephalography biomarker detects preclinical and clinical Alzheimer’s disease based on sensory gating mechanisms.

The team have filed a patent for the technology, and are currently exploring routes towards commercialisation so that it can be used to ultimately improve quality of life.

Dr Jasmine Sze, who completed this study as part of her PhD in the Department of Chemistry and has recently moved to the IMED Biotech at AstraZeneca said "Looking forward, with the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.

"It has great potential for biomarker discovery, development of companion diagnostics as well as clinical endeavours, such as direct diagnosis, prognosis and sub-type classification with single-molecule sensitivity."

Source-Eurekalert